Symbols / CTKB Stock $4.40 +3.29% Cytek Biosciences, Inc.

Healthcare • Medical Devices • United States • NMS
CTKB (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Medical Devices
CEO Dr. Wenbin Jiang Ph.D.
Exch · Country NMS · United States
Market Cap 565.62M
Enterprise Value 327.83M
Income -66.54M
Sales 201.49M
FCF (ttm) 4.33M
Book/sh 2.66
Cash/sh 2.03
Employees 702
Insider 10d —
IPO Jul 23, 2021
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E 73.33
PEG —
P/S 2.81
P/B 1.66
P/C —
EV/EBITDA -9.99
EV/Sales 1.63
Quick Ratio 4.29
Current Ratio 5.04
Debt/Eq 6.95
LT Debt/Eq —
EPS (ttm) -0.52
EPS next Y 0.06
EPS Growth —
Revenue Growth 8.10%
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-05-07
Earnings (prior) 2026-02-26
ROA -5.25%
ROE -18.05%
ROIC —
Gross Margin 51.84%
Oper. Margin -9.00%
Profit Margin -33.02%
Shs Outstand 128.55M
Shs Float 96.92M
Insider Own 8.42%
Instit Own 66.31%
Short Float 8.17%
Short Ratio 12.98
Short Interest 8.10M
52W High 6.18
vs 52W High -28.80%
52W Low 2.37
vs 52W Low 85.65%
Beta 1.28
Impl. Vol. 2.06%
Rel Volume 0.77
Avg Volume 738.17K
Volume 571.37K
Target (mean) $6.00
Tgt Median $5.75
Tgt Low $5.00
Tgt High $7.50
# Analysts 4
Recom Buy
Prev Close $4.26
Price $4.40
Change 3.29%
About

No company description available for this symbol.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
—
Latest analyst target
3. DCF / Fair value
$0.61
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
—
Low
—
High
—
Mean
—
News
RSS: Latest CTKB news

No recent news from Yahoo. Try the RSS feed for latest CTKB news.

Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-03-13 YAN MING Chief Technology Officer — 1,176,000 $0.00 $0
2026-03-10 YAN MING Chief Technology Officer — 25,400 — —
2026-03-10 MCCOMBE WILLIAM D. Chief Financial Officer — 23,721 — —
2026-03-10 BUSQUE PHILIPPE PH.D. Officer — 9,828 — —
2026-03-10 CHIN RICHARD M.D. PH.D. Director — 6,107 — —
2026-03-10 HOLDER MICHAEL Director — 2,908 — —
2026-03-10 BARNETT VALERIE Officer — 29,722 — —
2026-03-10 JIANG WENBIN Chief Executive Officer — 83,844 — —
2026-02-18 YAN MING Chief Technology Officer — 1,332 — —
2026-02-18 BARNETT VALERIE Officer — 1,346 — —
Financials

No financial statements available. Data is sourced from Yahoo Finance and cached; historical storage may be added later.

SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category